Pfizer CEO vows company will be a ‘formidable competitor’ in booming weight-loss market after $10B buy
Pfizer enters the lucrative weight-loss drug market with a massive $10 billion Metsera acquisition, targeting a $150-200 billion industry dominated by competitors.
